In conclusion, our study showed that following the DASH diet for 12 weeks in overweight and obese patients with NAFLD has beneficial effects on TAC, SOD, and visceral fat. This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.